Ropes & Gray Represents Sanofi in Investment in Draig Therapeutics’ $140 million Series A Financing

Ropes & Gray represented Sanofi in its investment in Draig Therapeutics’ $140 million Series A financing. Draig Therapeutics is a Cardiff-based clinical-stage company aiming to transform the treatment of neuropsychiatric diseases, launching from stealth. Draig Therapeutics was formed through a partnership with Cardiff University’s Medicines Discovery Institute.

The Ropes & Gray team included emerging companies and venture capital counsel David Dowling, emerging companies and venture capital associate Velyana Borisova and trainee Fang Chua, and emerging companies and venture capital partner Rajarshi Banerjee.